Apoptotic effects of antilymphocyte globulins on human pro-inflammatory CD4+CD28- T-cells

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Duftner, Christina ^a,b   Dejaco, Christian ^c   Hengster, Paul ^d   Bijuklic, Klaudija ^a   Joannidis, Michael ^a   Margreiter, Raimund ^d   Schirmer, Michael ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

^d Universitatsklinik fur Chirurgie Innsbruck   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILYMPHOCYTE GLOBULIN F; BENZYLOXYCARBONYLASPARTYLGLUTAMYLVALYLASPARTYL FLUOROMETHYL KETONE; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CX3CR1; CHEMOKINE RECEPTOR CXCR3; INTERLEUKIN 2 RECEPTOR ALPHA; L SELECTIN; LYMPHOCYTE ANTIBODY; PREDNISOLON 21 HYDROGEN SUCCINATE; SUCCINIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CD3+ CD4+ CD28- T LYMPHOCYTE; CD4+ CD28- T LYMPHOCYTE; CELL SURFACE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG MECHANISM; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GRAFT RECIPIENT; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SPACE; KIDNEY TRANSPLANTATION; LUNG TRANSPLANTATION; LYMPHOCYTE COUNT; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; RECEPTOR DOWN REGULATION; T CELL DEPLETION; T LYMPHOCYTE;

ADULT; ANTIGENS, CD28; ANTIGENS, CD3; ANTIGENS, CD95; ANTILYMPHOCYTE SERUM; APOPTOSIS; CASPASES; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; DOWN-REGULATION; ENZYME ACTIVATION; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; INFLAMMATION; INTERLEUKIN-2; LYMPHOCYTE DEPLETION; MALE; MIDDLE AGED; ORGAN TRANSPLANTATION; RECEPTORS, CHEMOKINE; SIGNAL TRANSDUCTION; TH1 CELLS; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION; YOUNG ADULT;

EID: 84859120859     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033939     Document Type: Article

References (50)

1. Mueller TF, (2003) Thymoglobulin: an immunologic overview. Curr Opin Organ Transplant 8: 305-312.
2. Marsh J, Schrezenmeier H, Marin P, Ilhan O, Ljungman P, et al. (1999) Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia: a report from the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anaemia Working Party. Blood 93: 2191-2195.
3. Tarkowski A, Andersson-Gäre B, Aurell M, (1993) Use of anti-thymocyte globulin in the management of refractory systemic autoimmune diseases. Scand J Rheumatol 22: 261-266.
4. Tarkowski A, Lindgren I, (1994) Beneficial effects of antithymocyte globulin in severe cases of progressive systemic sclerosis. Transplant Proc 26: 3197-3199.
5. Raefsky EL, Gascon P, Gratwohl A, Speck B, Young NS, (1986) Biological and immunological characterization of ATG and ALG. Blood 68: 712-719.
6. Bonnefoy-Berard N, Vincent C, Revillard JP, (1991) Antibodies against functional leukocyte surface molecules in polyclonal antilymphocyte and antithymocyte globulins. Transplantation 51: 669-673.
7. Rebellato LM, Gross U, Verbanac KM, Thomas JM, (1994) A comprehensive definition of the major antibody specificities in polyclonal rabbit antithymocyte globulin. Transplantation 57: 685-694.
8. Bonnefoy-Berard N, Revillard JP, (1996) Mechanisms of immunosuppression induced by antithymocyte globulins and OKT3. J Heart Lung Transplant 15: 435-442.
9. Genestier L, Fournel S, Flacher M, Assossou O, Revillard JP, et al. (1998) Induction of Fas (Apo-1, CD95)-mediated apoptosis of activated lymphocytes by polyclonal antithymocyte globulins. Blood 91: 2360-2368.
10. Michallet MC, Saltel F, Preville X, Flacher M, Revillard JP, et al. (2003) Cathepsin-B-dependent apoptosis triggered by antithymocyte globulins: a novel mechanism of T-cell depletion. Blood 102: 3719-3726.
11. Michallet MC, Preville X, Flacher M, Fournel S, Genestier L, et al. (2003) Functional antibodies to leukocyte adhesion molecules in antithymocyte globulins. Transplantation 75: 657-662.
12. Mohty M, (2007) Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond. Leukemia 21: 1387-1394.
13. Feng X, Kajigaya S, Solomou EE, Keyvanfar K, Xu X, et al. (2008) Rabbit ATG but not horse ATG promotes expansion of functional CD4+CD25highFOXP3+ regulatory T cells in vitro. Blood 111: 3675-3683.
14. Lowsky R, Takahashi T, Liu YP, Dejbakhsh-Jones S, Grumet FC, et al. (2005) Protective conditioning for acute graft-versus-host disease. N Engl J Med 353: 1321-1331.
15. Martens PB, Goronzy JJ, Schaid D, Weyand CM, (1997) Expansion of unusual CD4+ T cells in severe rheumatoid arthritis. Arthritis Rheum 40: 1106-1114.
16. Schmidt D, Goronzy JJ, Weyand CM, (1996) CD4+ CD7- CD28- T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity. J Clin Invest 97: 2027-2037.
17. Duftner C, Seiler R, Klein-Weigel P, Göbel H, Goldberger C, et al. (2005) High prevalence of circulating CD4+CD28- T-cells in patients with small abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 25: 1347-1352.
18. Duftner C, Goldberger C, Falkenbach A, Würzner R, Falkensammer B, et al. (2003) Prevalence, clinical relevance and characterization of circulating cytotoxic CD4+CD28- T cells in ankylosing spondylitis. Arthritis Res Ther 5: R292-300.
19. Markovic-Plese S, Cortese I, Wandinger KP, McFarland HF, Martin R, (2001) CD4+CD28- costimulation-independent T cells in multiple sclerosis. J Clin Invest 108: 1185-1194.
20. Lamprecht P, Moosig F, Csernok E, Seitzer U, Schnabel A, et al. (2001) CD28 negative T cells are enriched in granulomatous lesions of the respiratory tract in Wegener's granulomatosis. Thorax 56: 751-757.
21. Moosig F, Csernok E, Wang G, Gross WL, (1998) Costimulatory molecules in Wegener's granulomatosis (WG): lack of expression of CD28 and preferential up-regulation of its ligands B7-1 (CD80) and B7-2 (CD86) on T cells. Clin Exp Immunol 114: 113-118.
22. Pawlik A, Florczak M, Masiuk M, Dutkiewicz G, Machalinski B, et al. (2003) The expansion of CD4+CD28- T cells in patients with chronic kidney graft rejection. Transplant Proc 35: 2902-2904.
23. Pawlik A, Florczak M, Masiuk M, Machalinski B, Syczewska M, et al. (2003) The increased number of CD4+CD28- T cells in patients after liver transplantation. Ann Transplant 8: 54-56.
24. Schirmer M, Vallejo AN, Weyand CM, Goronzy JJ, (1998) Resistance to apoptosis and elevated expression of Bcl-2 in clonally expanded CD4+CD28- T cells from rheumatoid arthritis patients. J Immunol 161: 1018-1025.
25. Vallejo AN, Schirmer M, Weyand CM, Goronzy JJ, (2000) Clonality and longevity of CD4+CD28null T cells are associated with defects in apoptotic pathways. J Immunol 165: 6301-6307.
26. Warrington KJ, Kent PD, Frye RL, Lympt JF, Kopecky SL, et al. (2005) Rheumatoid arthritis is an independent risk factor for multi-vessel coronary artery disease: a case control study. Arthritis Res Ther 7: R984-991.
27. Yen JH, Moore BE, Nakajima T, Scholl D, Schaid DJ, et al. (2001) Major histocompatibility complex class I-recognizing receptors are disease risk genes in rheumatoid arthritis. J Exp Med 193: 1159-1167.
28. Goronzy JJ, Matteson EL, Fulbright JW, Warrington KJ, Chang-Miller A, et al. (2004) Prognostic markers of radiographic progression in early rheumatoid arthritis. Arthritis Rheum 50: 43-54.
29. Liuzzo G, Goronzy JJ, Yang H, Kopecky SL, Holmes DR, et al. (2000) Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation 101: 2883-2888.
30. Nakajima T, Schulte S, Warrington KJ, Kopecky SL, Frye RL, et al. (2002) T-cell-mediated lysis of endothelial cells in acute coronary syndromes. Circulation 105: 570-575.
31. Nadareishvili ZG, Li H, Wright V, Maric D, Warach S, et al. (2004) Elevated pro-inflammatory CD4+CD28- lymphocytes and stroke recurrence and death. Neurology 63: 1446-1451.
32. Studer SM, George MP, Zhu X, Song Y, Valentine VG, et al. (2008) CD28 down-regulation on CD4 T cells is a marker for graft dysfunction in lung transplant recipients. Am J Respir Crit Care Med 178: 765-773.
33. Mengel M, Mueller I, Behrend M, von Wasielewski R, Radermacher J, et al. (2004) Prognostic value of cytotoxic T-lymphocytes and CD40 in biopsies with early renal allograft rejection. Transpl Int 17: 293-300.
34. Han D, Xu X, Baidal D, Leith J, Ricordi C, et al. (2004) Assessment of cytotoxic lymphocyte gene expression in the peripheral blood of human islet allograft recipients: elevation precedes clinical evidence of rejection. Diabetes 53: 2281-2290.
35. Vallejo AN, Nestel AR, Schirmer M, Weyand CM, Goronzy JJ, (1998) Aging-related deficiency of CD28 expression in CD4+ T cells is associated with the loss of gene-specific nuclear factor binding activity. J Biol Chem 273: 8119-8129.
36. Goronzy JJ, Fulbright JW, Crowson CS, Poland GA, O'Fallon WM, et al. (2001) Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals. J Virol 75: 12182-12187.
37. Rizzello V, Liuzzo G, Brugaletta S, Rebuzzi A, Biasucci LM, et al. (2006) Modulation of CD4(+)CD28null T lymphocytes by tumor necrosis factor-alpha blockade in patients with unstable angina. Circulation 113: 2272-2277.
38. Bryl E, Vallejo AN, Matteson EL, Witkowski JM, Weyand CM, et al. (2005) Modulation of CD28 expression with anti-tumor necrosis factor alpha therapy in rheumatoid arthritis. Arthritis Rheum 52: 2996-3003.
39. Pawlik A, Ostanek L, Brzosko I, Brzosko M, Masiuk M, et al. (2004) Therapy with infliximab decreases the CD4+CD28- T cell compartment in peripheral blood in patients with rheumatoid arthritis. Rheumatol Int 24: 351-354.
40. Gerli R, Schillaci G, Giordano A, Bocci EB, Bistoni O, et al. (2004) CD4+CD28- T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients. Circulation 109: 2744-2748.
41. Brugaletta S, Biasucci LM, Pinnelli M, Biondi-Zoccai G, Di Giannuario G, et al. (2006) Novel anti-inflammatory effect of statins: reduction of CD4+CD28null T lymphocyte frequency in patients with unstable angina. Heart 92: 249-250.
42. Refaeli Y, Van Parijs L, London CA, Tschopp J, Abbas AK, (1998) Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis. Immunity 8: 615-623.
43. Ayuk FA, Fang L, Fehse B, Zander AR, Kröger N, (2005) Antithymocyte globulin induces complement-dependent cell lysis and caspase-dependent apoptosis in myeloma cells. Exp Hematol 33: 1531-1536.
44. Zhang X, Nakajima T, Goronzy JJ, Weyand CM, (2005) Tissue trafficking patterns of effector memory CD4+ T cells in rheumatoid arthritis. Arthritis Rheum 52: 3839-3849.
45. Beiras-Fenandez A, Thein E, Chappell D, Schropp A, Hammer C, (2004) Polyclonal antithymocyte globulins reduce the expression of IL-4 in a non-human primate model of ischemia-reperfusion injury. Transpl Immunol 13: 9-13.
46. Weimer R, Staak A, Süsal C, Streller S, Yildiz S, et al. (2005) ATG induction therapy: long-term effects on Th1 but not on Th2 responses. Transpl Int 18: 226-236.
47. Terasako K, Sato K, Sato M, Kimura S, Nakasone H, et al. (2010) The effect of different ATG preparations on immune recovery after allogeneic hematopoietic stem cell transplantation for severe aplastic anemia. Hematology 15: 165-169.
48. Penack O, Fischer L, Gentilini C, Nogai A, Muessig A, et al. (2007) The type of ATG matters - natural killer cells are influenced differentially by Thymoglobulin, Lymphoglobulin and ATG-Fresenius. Transpl Immunol 8: 85-87.
49. Dubey S, Nityanand S, (2003) Involvement of Fas and TNF pathways in the induction of apoptosis of T cells by antithymocyte globulin. Ann Hematol 82: 496-499.
50. Joannidis M, Truebsbach S, Bijuklic K, Schratzberger P, Dunzedorfer S, et al. (2004) Neutrophil transmigration in renal proximal tubular LLC-PK1 cells. Cell Physiol Biochem 14: 101-112.